Conformational stability of human interferon-gamma on association with and dissociation from liposomes

M L van Slooten1, A J Visser, A van Hoek

  • 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Pharmacy, Utrecht University, P.O. Box 80.082, 3508 TB Utrecht, The Netherlands.

Insights

Recombinant human interferon gamma (hIFNgamma) maintains its protein structure when interacting with liposomes, showing full conformational stability after desorption. This ensures therapeutic protein integrity in liposomal drug delivery systems.

Area of Science:

  • Biophysical Chemistry
  • Drug Delivery Systems
  • Protein Science

Background:

  • Therapeutic protein integrity is crucial for efficacy in delivery systems like liposomes.
  • Understanding protein-liposome interactions is key to developing stable formulations.
  • Recombinant human interferon gamma (hIFNgamma) is a therapeutic protein requiring careful formulation.

Purpose of the Study:

  • To investigate the conformational stability of hIFNgamma during and after interaction with liposomes.
  • To model hIFNgamma-liposome interactions using adsorption/desorption from empty liposomes.
  • To assess the impact of liposome preparation methods on protein conformation.

Main Methods:

  • Circular dichroism (CD) spectroscopy to analyze protein secondary and tertiary structure.
  • Steady-state and time-resolved fluorescence spectroscopy to probe the tryptophan (Trp-36) environment.
  • Acrylamide quenching studies to assess Trp-36 accessibility.

Main Results:

  • CD studies showed no significant changes in hIFNgamma secondary or tertiary structure upon liposome interaction.
  • Fluorescence spectroscopy indicated that the Trp-36 environment and accessibility were largely unaffected by adsorption/desorption.
  • Time-resolved fluorescence revealed protein immobilization on liposomes and subtle Trp-36 environment changes during liposome preparation.

Conclusions:

  • Association with negatively charged liposomes causes minimal structural changes to hIFNgamma.
  • All applied techniques confirm full retention or restoration of protein conformation after desorption.
  • hIFNgamma's conformational integrity is maintained in liposomal formulations, supporting its use in drug delivery.